BBY vs NBIX · P/E 14, rev $18.71B vs P/E 45, rev $1.77B
Best Buy Co. Inc (BBY) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the BBY and NBIX stock pages for the full models.
Not investment advice.